Tag results:

Industry & Policy News

‘It’s a Vote for Hope’: First Gene Therapy for Muscular Dystrophy Nears Approval, but Will It Work?

On 22 June, the US Food and Drug Administration would decide whether to grant a fast-track approval to the first gene therapy for Duchenne muscular dystrophy, a genetic disorder that affects...

EU Council’s ‘No Pay’ Publishing Model Draws Mixed Response

[Nature] The European Union’s council of ministers has called for the bloc to implement a ‘no pay’ academic-publishing model that bears no cost to readers or authors.

UW Carbone Cancer Center Receives Spore Designation, Federal Grant To Support Prostate Cancer Research

[University of Wisconsin] University of Wisconsin Carbone Cancer Center will be designated as a Specialized Program of Research Excellence, or SPORE, by the National Cancer Institute for research initiatives to advance new prostate cancer treatments.

AstraZeneca Drops Skyrizi Rival after Seeing R&D Timeline Spiral

[Fierce Biotech] AstraZeneca is abandoning a play for the inflammatory bowel disease market. After seeing clinical trial timelines spiral, the Anglo-Swedish drugmaker has stopped development of a would-be rival to products sold by AbbVie and Johnson & Johnson.

Council Calls for Transparent, Equitable, and Open Access to Scholarly Publications

[Council of the European Union] The Council has adopted conclusions on the ‘high quality, transparent, open, trustworthy and equitable scholarly publishing’, in which it calls for immediate and unrestricted open access in publishing research involving public funds.

Thousands of Early-Career NIH Researchers Forming Union for First Time

[Nature News] Thousands of early-career researchers at the US National Institutes of Health (NIH) have kick-started the process of forming a union. They are calling on the agency — the world’s largest biomedical funder — to raise pay and improve benefits, as well as to bolster its policies and procedures on harassment and excessive workloads.

Popular